RICCARDO, Federica
RICCARDO, Federica
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
A better immune reaction to Erbb-2
2010-01-01 Quaglino E; Mastini C; Riccardo F; Ercole E; Montani M; Forni G; Cavallo F
Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial
2022-01-01 Riccardo, Federica; Tarone, Lidia; Camerino, Mariateresa; Giacobino, Davide; Iussich, Selina; Barutello, Giuseppina; Arigoni, Maddalena; Conti, Laura; Bolli, Elisabetta; Quaglino, Elena; Merighi, Irene Fiore; Morello, Emanuela; Dentini, Alfredo; Ferrone, Soldano; Buracco, Paolo; Cavallo, Federica
Antitumor immunization of mothers delays tumor development in cancer-prone offspring
2015-01-01 Barutello, Giuseppina; Curcio, Claudia; Spadaro, Michela; Arigoni, Maddalena; Trovato, Rosalinda; Bolli, Elisabetta; Zheng, Yujuan; Ria, Francesco; Quaglino, Elena; Iezzi, Manuela; Riccardo, Federica; Holmgren, Lars; Forni, Guido; Cavallo, Federica
Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source
2019-01-01 Ruiu R.; Tarone L.; Rolih V.; Barutello G.; Bolli E.; Riccardo F.; Cavallo F.; Conti L.
Canine Melanoma and Osteosarcoma Immunotherapy by Means of In Vivo DNA Electroporation
2021-01-01 Tarone, Lidia; Buracco, Paolo; Cavallo, Federica; Riccardo, Federica
Canine Melanoma Immunology and Immunotherapy: Relevance of Translational Research
2022-01-01 Tarone L.; Giacobino D.; Camerino M.; Ferrone S.; Buracco P.; Cavallo F.; Riccardo F.
Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers.
2014-01-01 Riccardo F;Arigoni M;Buson G;Zago E;Iezzi M;Longo D;Carrara M;Fiore A;Nuzzo S;Bicciato S;Nanni P;Landuzzi L;Cavallo F;Calogero R;Quaglino E
Chimeric DNA Vaccines against ErbB2+ Carcinomas: From Mice to Humans.
2011-01-01 Quaglino E; Riccardo F; Macagno M; Bandini S; Cojoca R; Ercole E; Amici A; Cavallo F.
Chimeric DNA Vaccines: An Effective Way to Overcome Immune Tolerance.
2017-01-01 F. Riccardo;E. Bolli;M. Macagno;M. Arigoni;F. Cavallo;E. Quaglino
CSPG4-specific immunity and survival prolongation in dogs with oral malignant melanoma immunized with human CSPG4 DNA
2014-01-01 F. Riccardo; S. Iussich; L. Maniscalco; S. Lorda Mayayo; G. L. Rosa; M. Arigoni; R. De Maria; F. Gattino; S. Lanzardo; E. Lardone; M. Martano; E. Morello; S. Prestigio; A. Fiore; E. Quaglino; S. Zabarino; S. Ferrone; P. Buracco; F. Cavallo
CSPG4: a prototype oncoantigen for translational immunotherapy studies
2017-01-01 Rolih, Valeria; Barutello, Giuseppina; Iussich, Selina; De Maria, Raffaella; Quaglino, Elena; Buracco, Paolo; Cavallo, Federica; Riccardo, Federica
Deregulation of MicroRNAs mediated control of carnitine cycle in prostate cancer: molecular basis and pathophysiological consequences
2017-01-01 Valentino, A; Calarco, A; Di Salle, A; Finicelli, M; Crispi, S; Calogero, R A; Riccardo, F; Sciarra, A; Gentilucci, A; Galderisi, U; Margarucci, S; Peluso, G
Development of a vlp-based vaccine displaying an XCT extracellular domain for the treatment of metastatic breast cancer
2020-01-01 Rolih V.; Caldeira J.; Bolli E.; Salameh A.; Conti L.; Barutello G.; Riccardo F.; Magri J.; Lamolinara A.; Parra K.; Valenzuela P.; Francia G.; Iezzi M.; Pericle F.; Cavallo F.
Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases
2021-01-01 Giacobino D.; Camerino M.; Riccardo F.; Cavallo F.; Tarone L.; Martano M.; Dentini A.; Iussich S.; Lardone E.; Franci P.; Valazza A.; Manassero L.; Del Magno S.; De Maria R.; Morello E.; Buracco P.
Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases
2021-01-01 Giacobino D.; Camerino M.; Riccardo F.; Cavallo F.; Tarone L.; Martano M.; Dentini A.; Iussich S.; Lardone E.; Franci P.; Valazza A.; Manassero L.; Del Magno S.; De Maria R.; Morello E.; Buracco P.
Evaluation of prognostic impact of pre‐treatment neutrophil to lymphocyte and lymphocyte to monocyte ratios in dogs with oral malignant melanoma treated with surgery and adjuvant CSPG4‐antigen electrovaccination: an explorative study
2021-01-01 Mariateresa Camerino, Davide Giacobino, Selina Iussich, Ugo Ala, Federica Riccardo, Federica Cavallo, Marina Martano, Emanuela Morello, Paolo Buracco
Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter
2019-01-01 Ruiu, Roberto*; Rolih, Valeria; Bolli, Elisabetta; Barutello, Giuseppina; Riccardo, Federica; Quaglino, Elena; Merighi, Irene Fiore; Pericle, Federica; Donofrio, Gaetano; Cavallo, Federica; Conti, Laura
HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy.
2011-01-01 Zizzari IG; Veglia F; Taurino F; Rahimi H; Quaglino E; Belleudi F; Riccardo F; Antonilli M; Napoletano C; Bellati F; Benedetti-Panici P; Torrisi MR; Frati L; Nuti M; Rughetti A.
HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer
2022-01-01 Wang, Junbiao; Lamolinara, Alessia; Conti, Laura; Giangrossi, Mara; Cui, Lishan; Morelli, Maria Beatrice; Amantini, Consuelo; Falconi, Maurizio; Bartolacci, Caterina; Andreani, Cristina; Orlando, Fiorenza; Provinciali, Mauro; Del Pizzo, Francesco Domenico; Russo, Francesca; Belletti, Barbara; Riccardo, Federica; Bolli, Elisabetta; Quaglino, Elena; Cavallo, Federica; Amici, Augusto; Iezzi, Manuela; Marchini, Cristina
Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma
2019-01-01 Riccardo F, Tarone L, Iussich S, Giacobino D, Arigoni M, Sammartano F, Morello E, Martano M, Gattino F, De Maria R., Ferrone S, Buracco P, Cavallo F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A better immune reaction to Erbb-2 | 2010 | Quaglino E; Mastini C; Riccardo F; Ercole E; Montani M; Forni G; Cavallo F | |
| Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial | 2022 | Riccardo, Federica; Tarone, Lidia; Camerino, Mariateresa; Giacobino, Davide; Iussich, Selina; Barutello, Giuseppina; Arigoni, Maddalena; Conti, Laura; Bolli, Elisabetta; Quaglino, Elena; Merighi, Irene Fiore; Morello, Emanuela; Dentini, Alfredo; Ferrone, Soldano; Buracco, Paolo; Cavallo, Federica | |
| Antitumor immunization of mothers delays tumor development in cancer-prone offspring | 2015 | Barutello, Giuseppina; Curcio, Claudia; Spadaro, Michela; Arigoni, Maddalena; Trovato, Rosalinda; Bolli, Elisabetta; Zheng, Yujuan; Ria, Francesco; Quaglino, Elena; Iezzi, Manuela; Riccardo, Federica; Holmgren, Lars; Forni, Guido; Cavallo, Federica | |
| Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source | 2019 | Ruiu R.; Tarone L.; Rolih V.; Barutello G.; Bolli E.; Riccardo F.; Cavallo F.; Conti L. | |
| Canine Melanoma and Osteosarcoma Immunotherapy by Means of In Vivo DNA Electroporation | 2021 | Tarone, Lidia; Buracco, Paolo; Cavallo, Federica; Riccardo, Federica | |
| Canine Melanoma Immunology and Immunotherapy: Relevance of Translational Research | 2022 | Tarone L.; Giacobino D.; Camerino M.; Ferrone S.; Buracco P.; Cavallo F.; Riccardo F. | |
| Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers. | 2014 | Riccardo F;Arigoni M;Buson G;Zago E;Iezzi M;Longo D;Carrara M;Fiore A;Nuzzo S;Bicciato S;Nanni P;Landuzzi L;Cavallo F;Calogero R;Quaglino E | |
| Chimeric DNA Vaccines against ErbB2+ Carcinomas: From Mice to Humans. | 2011 | Quaglino E; Riccardo F; Macagno M; Bandini S; Cojoca R; Ercole E; Amici A; Cavallo F. | |
| Chimeric DNA Vaccines: An Effective Way to Overcome Immune Tolerance. | 2017 | F. Riccardo;E. Bolli;M. Macagno;M. Arigoni;F. Cavallo;E. Quaglino | |
| CSPG4-specific immunity and survival prolongation in dogs with oral malignant melanoma immunized with human CSPG4 DNA | 2014 | F. Riccardo; S. Iussich; L. Maniscalco; S. Lorda Mayayo; G. L. Rosa; M. Arigoni; R. De Maria; F. Gattino; S. Lanzardo; E. Lardone; M. Martano; E. Morello; S. Prestigio; A. Fiore; E. Quaglino; S. Zabarino; S. Ferrone; P. Buracco; F. Cavallo | |
| CSPG4: a prototype oncoantigen for translational immunotherapy studies | 2017 | Rolih, Valeria; Barutello, Giuseppina; Iussich, Selina; De Maria, Raffaella; Quaglino, Elena; Buracco, Paolo; Cavallo, Federica; Riccardo, Federica | |
| Deregulation of MicroRNAs mediated control of carnitine cycle in prostate cancer: molecular basis and pathophysiological consequences | 2017 | Valentino, A; Calarco, A; Di Salle, A; Finicelli, M; Crispi, S; Calogero, R A; Riccardo, F; Sciarra, A; Gentilucci, A; Galderisi, U; Margarucci, S; Peluso, G | |
| Development of a vlp-based vaccine displaying an XCT extracellular domain for the treatment of metastatic breast cancer | 2020 | Rolih V.; Caldeira J.; Bolli E.; Salameh A.; Conti L.; Barutello G.; Riccardo F.; Magri J.; Lamolinara A.; Parra K.; Valenzuela P.; Francia G.; Iezzi M.; Pericle F.; Cavallo F. | |
| Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases | 2021 | Giacobino D.; Camerino M.; Riccardo F.; Cavallo F.; Tarone L.; Martano M.; Dentini A.; Iussich S.; Lardone E.; Franci P.; Valazza A.; Manassero L.; Del Magno S.; De Maria R.; Morello E.; Buracco P. | |
| Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases | 2021 | Giacobino D.; Camerino M.; Riccardo F.; Cavallo F.; Tarone L.; Martano M.; Dentini A.; Iussich S.; Lardone E.; Franci P.; Valazza A.; Manassero L.; Del Magno S.; De Maria R.; Morello E.; Buracco P. | |
| Evaluation of prognostic impact of pre‐treatment neutrophil to lymphocyte and lymphocyte to monocyte ratios in dogs with oral malignant melanoma treated with surgery and adjuvant CSPG4‐antigen electrovaccination: an explorative study | 2021 | Mariateresa Camerino, Davide Giacobino, Selina Iussich, Ugo Ala, Federica Riccardo, Federica Cavallo, Marina Martano, Emanuela Morello, Paolo Buracco | |
| Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter | 2019 | Ruiu, Roberto*; Rolih, Valeria; Bolli, Elisabetta; Barutello, Giuseppina; Riccardo, Federica; Quaglino, Elena; Merighi, Irene Fiore; Pericle, Federica; Donofrio, Gaetano; Cavallo, Federica; Conti, Laura | |
| HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy. | 2011 | Zizzari IG; Veglia F; Taurino F; Rahimi H; Quaglino E; Belleudi F; Riccardo F; Antonilli M; Napoletano C; Bellati F; Benedetti-Panici P; Torrisi MR; Frati L; Nuti M; Rughetti A. | |
| HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer | 2022 | Wang, Junbiao; Lamolinara, Alessia; Conti, Laura; Giangrossi, Mara; Cui, Lishan; Morelli, Maria Beatrice; Amantini, Consuelo; Falconi, Maurizio; Bartolacci, Caterina; Andreani, Cristina; Orlando, Fiorenza; Provinciali, Mauro; Del Pizzo, Francesco Domenico; Russo, Francesca; Belletti, Barbara; Riccardo, Federica; Bolli, Elisabetta; Quaglino, Elena; Cavallo, Federica; Amici, Augusto; Iezzi, Manuela; Marchini, Cristina | |
| Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma | 2019 | Riccardo F, Tarone L, Iussich S, Giacobino D, Arigoni M, Sammartano F, Morello E, Martano M, Gattino F, De Maria R., Ferrone S, Buracco P, Cavallo F. |